| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0002 |
| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.001 |